資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/32508
|
| 標題: | Identification of baicalin from Bofutsushosan and Daisaikoto as a potent inducer of glucose uptake and modulator of insulin signaling-associated pathways |
| 作者: | Kuo, Yu-Ting
Lin, Chih-Chan
Hsiao-Tzu Kuo(郭小慈)
Jui-Hsiang Hung(洪瑞祥)
Liu, Ching-Hsuan
Jassey, Alagie
Yen, Ming-Hong
Shu-Jing Wu(吳淑靜)
Lin, Liang-Tzung |
| 貢獻者: | Chi Mei Med Ctr, Dept Med Imaging
Chi Mei Med Ctr, Dept Med Res
Chia Nan Univ Pharm & Sci, Dept Nutr Hlth
Chia Nan Univ Pharm & Sci, Dept Biotechnol
Taipei Med Univ, Grad Inst Med Sci, Coll Med
Dalhousie Univ, Dept Microbiol & Immunol
Taipei Med Univ, Coll Med, Int PhD Program Med
Kaohsiung Med Univ, Coll Pharm, Grad Inst Nat Prod
Taipei Med Univ, Sch Med, Dept Microbiol & Immunol, Coll Med |
| 關鍵字: | Anti-hyperglycemia
Baicalin
Bofutsushosan
Daisaikoto
Glucose uptake |
| 日期: | 2019-01 |
| 上傳時間: | 2020-07-29 13:47:52 (UTC+8) |
| 出版者: | FOOD & DRUG ADMINSTRATION |
| 摘要: | Type 2 diabetes mellitus (T2DM) is a chronic disease characterized by hyperglycemia that can lead to long-term complications including heart diseases, stroke, retinopathy, and renal failure. Treatment strategies include stimulating glucose uptake and controlling blood glucose level. Bofutsushosan (BOF) and Daisaikoto (DAI) are two herb-based kampo medicines that have been demonstrated to improve metabolism-associated disorders including obesity, hyperlipidemia, and nonalcoholic fatty liver. Given their bioactivities against metabolic syndromes, we explored in this study the effect of BOF and DAI extracts on glucose absorption and used them as source to identify phytochemical stimulator of glucose absorption. Glucose uptake and mechanistic studies were evaluated in differentiated C2C12 skeletal muscle cells, and HPLC analysis was used to determine the molecular bioactive constituents. Our results indicated that the ethanolic extracts of BOF and DAI (BOFEE and DAIEE, respectively) enhanced the glucose uptake ratio in the differentiated C2C12 cells, and further analysis identified the flavone baicalin as a major constituent capable of efficiently stimulating glucose absorption. Mechanistic studies revealed that the effect from baicalin involved the activation of IRS-1 and GLUT-4, and implicated the AMPK, PI3K/Akt, and MAPK/ERK signaling cascades. Due to its potency, we suggest that baicalin merit further evaluation as a potential candidate anti-hyperglycemic agent for the treatment and management of T2DM. Copyright (C) 2018, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC. |
| 關聯: | Journal of Food and Drug Analysis, v.27, n.1, pp.240-248 |
| 顯示於類別: | [保健營養系(所) ] 期刊論文
[生物科技系(所)] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| 10.1016-j.jfda.2018.07.002.pdf | | 880Kb | Adobe PDF | 385 | 檢視/開啟 | | index.html | | 0Kb | HTML | 1165 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
